Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Evolution of GLP‐1 Receptor Agonists
Description
GLP-1 receptor agonists are now used for the treatment of type 2 diabetes and obesity. Looking back, GLP-1 was found to be a cleavage product of proglucagon processing.A key breakthrough came from the discovery of exendin-4.Exendin-4 is a peptide with agonistic properties at the GLP-1 receptor but resistance to degradation by DPP-4.Semaglutide, the first oral GLP-1 receptor agonist, marked the next milestone. https://www.medicilon.com/videos/glp-1-receptor-agonists-evolution/
Keywords & Tags
More from User
03:30
Medicilon: Integrated Preclinical CRO for One-stop R&D Services
Jenny zou
01:28
Nociceptive Pain-Neural System Disease Models
Jenny zou
01:25
Introduction of STAT3
Jenny zou
01:13
KRAS Mutations and Cancer
Jenny zou
01:22
Timeline of KRAS Inhibitors
Jenny zou
01:01
Signaling Pathway of KRAS
Jenny zou
Related Videos
06:52
Understanding the Potential of GLP-1 Agonists in Alzheimer's Disease|What Are GLP-1 Agonists and How Do They Affect Alzheimer’s Disease?
doctormohdasif
05:39
Agonist, Partial Agonist, Antagonist and Inverse Agonist for Receptors
CREATIVE MIND
03:28
GLP-1 Agonists - Edelman Report
Lila Flores
00:21
Aarkstore - Interleukin-2 (IL-2) Receptor Agonists -Pipeline Insights, 2014
Addy Parker
00:35
Evolution and Vertebrate Immunity: The Antigen-Receptor and Mhc Gene Families (University of
fudupoyo
00:50
What is ENDOGENOUS AGONIST? What does ENDOGENOUS AGONIST mean? ENDOGENOUS AGONIST meaning - ENDOGENOUS AGONIST definition - ENDOGENOUS AGONIST explanation
The Audiopedia